Stimulant Use Clinical Trials

5 recruiting

Stimulant Use Trials at a Glance

12 actively recruiting trials for stimulant use are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Minneapolis, Dallas, and Houston. Lead sponsors running stimulant use studies include University of Minnesota, Korea University Anam Hospital, and Indiana University.

Browse stimulant use trials by phase

Treatments under study

About Stimulant Use Clinical Trials

Looking for clinical trials for Stimulant Use? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stimulant Use trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stimulant Use clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

Stimulant Use (Diagnosis)
Northwestern University76 enrolled9 locationsNCT05702021
Recruiting
Not Applicable

Enhancing Prospective Thinking in Early Recovery

Substance Use DisordersStimulant Use
Indiana University200 enrolled1 locationNCT05835921
Recruiting
Phase 1

Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder

Stimulant Use Disorder
University of Minnesota50 enrolled1 locationNCT06790576
Recruiting
Not Applicable

Project neuroARTEMIS

DepressionStimulant UseHuman Immunodeficiency Virus (HIV)
Wake Forest University Health Sciences189 enrolled1 locationNCT06814275
Recruiting
Phase 2

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Stimulant Use Disorder
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT06444256
Recruiting
Not Applicable

A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD)

Psychostimulant Use Disorder(PUD)
Korea University Anam Hospital10 enrolled1 locationNCT06474026
Recruiting
Not Applicable

Neuromodulation and Cognitive Training for Substance Use Disorders

Alcohol Use DisorderStimulant Use
University of Minnesota80 enrolled1 locationNCT04426214
Recruiting
Not Applicable

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

People Living With HIVStimulant Use DisorderreSET
University of Miami500 enrolled1 locationNCT05958017
Recruiting
Not Applicable

Accelerated rTMS for Substance Use Disorder and Depression

DepressionStimulant Use
University of Texas Southwestern Medical Center40 enrolled1 locationNCT06424184
Recruiting
Not Applicable

Smartphone Services for Stimulant Use Disorder

Stimulant Use Disorder
DynamiCare Health270 enrolled1 locationNCT07092059
Recruiting
Phase 2

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment

Stimulant Use Disorder
Washington State University60 enrolled1 locationNCT06323837
Recruiting
Phase 2

Acute Effects of Stimulant Medication in College Students With ADHD

Attention Deficit Hyperactivity DisorderWorking MemoryMood+2 more
University of Wyoming40 enrolled1 locationNCT03935646